About the company
The Tekla World Healthcare Fund, a prominent non-diversified closed-end management investment company, has a clear and focused investment objective: to seek current income and long-term capital appreciation through strategic investments in both U.S. and non-U.S. companies operating within the ever-evolving healthcare industry. With an extensive and carefully constructed investment portfolio, Tekla World Healthcare Fund is constantly on the lookout for opportunities in various sub-sectors within the healthcare industry. By taking a diversified approach, the fund aims to minimize risk while maximizing returns for its investors. One of the primary areas of interest for the fund is the pharmaceutical and biotechnology sector. This rapidly advancing field offers immense potential, as companies develop innovative drugs and therapies to combat diseases and improve overall health. The fund strategically selects investments in pharmaceutical and biotech companies that demonstrate promising pipelines, solid research and development capabilities, and potential for growth. In addition to pharmaceutical and biotech companies, the fund also invests in healthcare providers and services. This sector encompasses a wide range of subsectors, including hospitals, clinics, nursing homes, and home healthcare services. The fund seeks out investments in well-managed healthcare providers that offer essential services and have sustainable business models. By investing in this sector, the fund aims to benefit from the increasing demand for healthcare services driven by an aging population and advancements in medical technology. Real estate investment trusts (REITs) focused on healthcare-related properties represent another key area of investment for the fund. These REITs own and manage properties such as hospitals, medical office buildings, and assisted living facilities. By investing in REITs, the fund gains exposure to the growing demand for healthcare-related real estate while potentially benefiting from regular income generated by leases and rental agreements. The fund also recognizes the importance of medical devices and diagnostics in the healthcare industry. With technological advancements driving innovation in this field, Tekla World Healthcare Fund strategically invests in companies that develop and manufacture cutting-edge medical devices and diagnostic tools. These investments can range from companies specializing in robotic surgery systems to those involved in the development of diagnostic tests for various diseases. Furthermore, the fund keeps a close eye on emerging areas within the healthcare industry. This includes investments in companies exploring fields such as telemedicine, genomics, digital health, and personalized medicine. By staying at the forefront of these trends, the fund aims to identify promising investment opportunities and provide potential long-term capital appreciation for its investors. In summary, the Tekla World Healthcare Fund is committed to seeking current income and long-term capital appreciation by investing in a diversified portfolio of U.S. and non-U.S. companies engaged in the healthcare industry. With investments spread across various sub-sectors such as pharmaceuticals and biotechnology, healthcare providers and services, REITs, medical devices and diagnostics, and emerging areas within healthcare, the fund aims to capitalize on the ongoing advancements and growing demand within this vital sector. Investors in the Tekla World Healthcare Fund can participate in the potentially lucrative opportunities offered by the dynamic and ever-evolving healthcare industry.
Data updated: June 2, 2026
